STOWHEALTH — All Prescriptions & Medications — Page 16
Practice Code: D83044 | STOWMARKET, IP14 1NL
Showing results 751-787 of 787
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 12 | 180 | £653 | +60.0% ▲ | |
| Naloxegol | 11 | 298 | £521 | -20.2% ▼ |
| Naftidrofuryl oxalate | 11 | 924 | £107 | -66.2% ▼ |
| Levomepromazine maleate | 11 | 274 | £71 | +19.8% ▲ |
| Rimegepant | 11 | 88 | £1.1K | +12.1% ▲ |
| Perampanel | 11 | 308 | £1.5K | -49.2% ▼ |
| Glimepiride | 11 | 320 | £11 | -88.1% ▼ |
| Tamsulosin and dutasteride hydrochloride | 11 | 330 | £89 | -68.5% ▼ |
| Propiverine hydrochloride | 11 | 616 | £511 | -26.5% ▼ |
| Oral rehydration salts | 11 | 238 | £109 | -61.9% ▼ |
| 11 | 125 | £70 | -63.2% ▼ | |
| 11 | 11 | £439 | +173.1% ▲ | |
| 11 | 480 | £23 | -79.7% ▼ | |
| 11 | 14 | £582 | +26.3% ▲ | |
| 11 | 330 | £206 | -57.8% ▼ | |
| 11 | 85 | £99 | -36.1% ▼ | |
| 11 | 1,855 | £115 | -89.2% ▼ | |
| 11 | 330 | £948 | +71.8% ▲ | |
| 11 | 320 | £587 | +26.8% ▲ | |
| Balsalazide sodium | 10 | 560 | £126 | -32.9% ▼ |
| Codeine phosphate | 10 | 3,740 | £130 | -30.3% ▼ |
| Ivermectin | 10 | 96 | £1.2K | +2.5% ▲ |
| Zinc sulfate | 10 | 300 | £62 | -18.8% ▼ |
| Ready to serve 2.4 kcal/ml milkshake higher volume (0913011) | 10 | 73.0K | £445 | -50.6% ▼ |
| Powder micronutrient supplement (0913284) | 10 | 300 | £1.0K | +43.3% ▲ |
| Tube feed 1 kcal/ml soya based with fibre (0914033) | 10 | 322.5K | £5.8K | +39.2% ▲ |
| Cyclopentolate hydrochloride | 10 | 50 | £81 | +74.8% ▲ |
| Timolol and brimonidine | 10 | 55 | £104 | -28.7% ▼ |
| Betamethasone sodium phosphate | 10 | 100 | £23 | +50.1% ▲ |
| Mometasone furoate/olopatadine hydrochloride | 10 | 10 | £118 | -8.0% ▼ |
| Chlorhexidine gluconate | 10 | 4,900 | £56 | -54.5% ▼ |
| 10 | 57 | £136 | +12.4% ▲ | |
| 10 | 88 | £591 | -51.3% ▼ | |
| 10 | 10 | £115 | +63.5% ▲ | |
| 10 | 720 | £2.2K | +39.2% ▲ | |
| 10 | 200 | £969 | -18.5% ▼ | |
| 10 | 300 | £402 | -38.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.